![Quiver Logo](/static/img/logo-icon.png)
![BFRIW logo](https://quiver-logos.s3.us-east-2.amazonaws.com/bfriw.png)
Biofrontera Inc. Warrants
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BFRIW Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of BFRIW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by BFRIW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to BFRIW
Recent picks made for BFRIW stock on CNBC
ETFs with the largest estimated holdings in BFRIW
Flights by private jets registered to BFRIW
![Quiver Logo](/static/img/logo-icon.png)